Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 5/20 | 0.56 |
| ▸ | TYR | P14679 | 3/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | TP53 | P04637 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
| ▸ | HTT | P42858 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.56 |
| ▸ | PTGS2 | P35354 | 6/20 | 0.50 |
| ▸ | RBP1 | P09455 | 1/20 | 0.47 |
| ▸ | PTGES | O14684 | 1/20 | 0.47 |
| ▸ | TOP2A | P11388 | 1/20 | 0.47 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.43 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.42 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29684086 | 1.00 | ALOX5 (0.56) | ALOX5TYRCYP3A4MEN1TP53 | |
| SCHEMBL23628389 | 0.86 | PTPN1 (0.55) | ALOX5TYRCYP3A4MEN1TP53 | |
| SCHEMBL29633513 | 0.81 | ALOX5 (0.47) | ALOX5TYRCYP3A4MEN1TP53 | |
| SCHEMBL13862945 | 0.81 | ALOX5 (0.59) | ALOX5TYRCYP3A4MEN1TP53 | |
| SCHEMBL17867241 | 0.79 | ALOX5 (0.65) | ALOX5TYRCYP3A4MEN1TP53 | |
| SCHEMBL3515735 | 0.79 | ALOX5 (0.58) | ALOX5TYRCYP3A4MEN1TP53 | |
| SCHEMBL16431532 | 0.79 | ALOX5 (0.65) | ALOX5TYRCYP3A4MEN1TP53 | |
| SCHEMBL3204289 | 0.79 | ALOX5 (0.65) | ALOX5TYRCYP3A4MEN1TP53 | |
| SCHEMBL29424247 | 0.79 | ALOX5 (0.58) | ALOX5TYRCYP3A4MEN1TP53 | |
| SCHEMBL23628391 | 0.79 | PTPN1 (0.47) | ALOX5TYRCYP3A4MEN1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250090494-A1 | CANNABIDIOL COMPOSITIONS HAVING MODIFIED CANNABINOID PROFILES | NORAMCO, LLC | 2025-03-20 | — | — | US | claimed |
| US-12144795-B2 | Cannabidiol compositions having modified cannabinoid profiles | PURISYS LLC (US) | 2024-11-19 | — | — | US | claimed |
| US-20220218651-A1 | CANNABIDIOL COMPOSITIONS HAVING MODIFIED CANNABINOID PROFILES | NORAMCO, LLC | 2022-07-14 | — | — | US | claimed |
| EP-3847148-A2 | CANNABIDIOL COMPOSITIONS HAVING MODIFIED CANNABINOID PROFILES | Purisys LLC (US) | 2021-07-14 | — | — | EP | claimed |
| US-20210061781-A1 | PROCESS FOR THE PRODUCTION OF CANNABIDIOL AND DELTA-9-TETRAHYDROCANNABINOL | NORAMCO, INC. | 2021-03-04 | — | — | US | claimed |
| US-10844035-B2 | Process for the production of cannabidiol and delta-9-tetrahydrocannabinol | PURISYS LLC (US) | 2020-11-24 | — | — | US | claimed |
| EP-3722276-A1 | PROCESS FOR THE PRODUCTION OF CANNABIDIOL AND PURIFIED CANNABIDIOL | Purisys LLC (US) | 2020-10-14 | — | — | EP | claimed |
| EP-0623339-B1 | Use of 4-,4- and 5-, or 4- and 6-substituted derivatives of resorcin in cosmetic or dermopharmaceutical compositions for depigmentation | OREAL (FR) | 1997-07-23 | — | — | EP | claimed |
| US-20250090494-A1 | CANNABIDIOL COMPOSITIONS HAVING MODIFIED CANNABINOID PROFILES | NORAMCO, LLC | 2025-03-20 | — | — | US | disclosed |
| US-12144795-B2 | Cannabidiol compositions having modified cannabinoid profiles | PURISYS LLC (US) | 2024-11-19 | — | — | US | disclosed |
| US-20220242810-A1 | CRYSTALLINE CANNABIGEROL | NORAMCO, INC. | 2022-08-04 | — | — | US | disclosed |
| US-20220218651-A1 | CANNABIDIOL COMPOSITIONS HAVING MODIFIED CANNABINOID PROFILES | NORAMCO, LLC | 2022-07-14 | — | — | US | disclosed |
| EP-3847148-A2 | CANNABIDIOL COMPOSITIONS HAVING MODIFIED CANNABINOID PROFILES | Purisys LLC (US) | 2021-07-14 | — | — | EP | disclosed |
| WO-2021007661-A1 | CANNABINOID DERIVATIVES | CANOPY GROWTH CORPORATION (CA) | 2021-01-21 | — | — | WO | disclosed |
| WO-2020252369-A1 | CRYSTALLINE CANNABIGEROL | PURISYS LLC (US) | 2020-12-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10844035-B2 | Process for the production of cannabidiol and delta-9-tetrahydrocannabinol | SQLE, CNR2, DAGLA | ALOX5 34/4885TYR 460/4885CYP3A4 186/4885 |
| US-20250090494-A1 | CANNABIDIOL COMPOSITIONS HAVING MODIFIED CANNABINOID PROFILES | MGLL, CNR2, HDHD5 | ALOX5 161/4885TYR 1538/4885CYP3A4 662/4885 |
| US-12144795-B2 | Cannabidiol compositions having modified cannabinoid profiles | MGLL, CNR2, HDHD5 | ALOX5 161/4885TYR 1538/4885CYP3A4 662/4885 |
| US-20220218651-A1 | CANNABIDIOL COMPOSITIONS HAVING MODIFIED CANNABINOID PROFILES | MGLL, CNR2, HDHD5 | ALOX5 161/4885TYR 1538/4885CYP3A4 662/4885 |
| US-20210061781-A1 | PROCESS FOR THE PRODUCTION OF CANNABIDIOL AND DELTA-9-TETRAHYDROCANNABINOL | CNR2, HDHD5, DAGLA | ALOX5 78/4885TYR 805/4885CYP3A4 386/4885 |
| US-20220242810-A1 | CRYSTALLINE CANNABIGEROL | CNR2, CNR1, UGT8 | ALOX5 1933/4885TYR 4599/4885CYP3A4 1508/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.